Skip to main content
SpringerLink
Log in

Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells

  • Minireview
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Experimental allergic encephalomyelitis (EAE) is an inflammatory demyelinating disease of the central nervous system (CNS) which has many clinical and pathological features in common with multiple sclerosis (MS). Comparison of the histopathology of EAE and MS reveals a close similarity suggesting that these two diseases share common pathogenetic mechanisms. Immunologic processes are widely accepted to contribute to the initiation and continuation of the diseases and recent studies have indicated that microglia, astrocytes and the infiltrating immune cells have separate roles in the pathogenesis of the MS lesion (1,2). The role of cytokines as important regulatory elements in these immune processes has been well established in EAE and the presence of cytokines in cells at the edge of MS lesions has also been observed (3–7). However, the role of chemokines in the initial inflammatory process as well as in the unique demyelinating event associated with MS and EAE has only recently been examined. A few studies have detected the transient presence of selected chemokines at the earliest sign of leukocyte infiltration of CNS tissue and have suggested astrocytes as their cellular source (8–10). Based on these studies, chemokines have been postulated as a promising target for future therapy of CNS inflammation. This review summarizes the events that occur during the inflammatory process in EAE and discusses the roles of cytokine and chemokine expression by the resident and infiltrating cells participating in the process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Williams, K. C., Ulvestad, E., and Hickey, W. F. 1994. Immunology of multiple sclerosis. Clinical Neurosci. 2:229–245.

    CAS  Google Scholar 

  2. Trapp, B. D., and Bo, L. 1995. Cellular mechanisms of demyelination in multiple sclerosis brains. J. Neurochem. 64 Suppl. S74A

    Google Scholar 

  3. Waksman, B. H., and Reynolds, W. E. 1984. Multiple sclerosis as a disease of immune regulation (41798). Proc. Soc. Exp Biol Med. 175:282–294.

    PubMed  CAS  Google Scholar 

  4. Raine, C. S. 1994. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion. Ann. Neurol. 36: (Suppl):S61-S72.

    Article  PubMed  CAS  Google Scholar 

  5. Raine, C. S. 1994b. Multiple Sclerosis: immune system molecule expression in the central nervous system. J. Neuropathol. and Exp. Neurol 53:328–337

    CAS  Google Scholar 

  6. Ransohoff, R. M., Tuohy, V., and Lehmann, P. 1994. The immunology of multiple sclerosis: new intricacies and new insights. Current Opinion in Neurology 7:242–249.

    PubMed  CAS  Google Scholar 

  7. Tani, M., and Ransohoff, R. M. 1994. Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyna? Brain Pathol. 4:135–143.

    PubMed  CAS  Google Scholar 

  8. Brosnan, C. F., Shafit-Zagardo, B., Aquino, D. A., and Berman, J. W. 1993. Expression of monocyte/macrophage growth factors and receptors in the central nervous system. Adv. Neurol. 59:349–361.

    PubMed  CAS  Google Scholar 

  9. Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., Estes, M. L., Thomas, D. M., and Tuohy, V. K.: 1993. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:592–600.

    PubMed  CAS  Google Scholar 

  10. Glabinski, A. R., Babcock, G. T., Aras, S., Chaturvedi, P., Stoler, M. S., Tuohy, V. K., Hamilton, T. A., and Ransohoff. R. M. 1995. Astrocyte-derived chemokines and CNS inflammation. J. Neurochem. 64 Suppl. S74C.

  11. Logan, A., and Berry, M. 1993. Transforming growth factor β1 and basic fibroblast growth factor in the injured CNS. TIPS 14:337–343.

    PubMed  CAS  Google Scholar 

  12. Lotan, M., and Schwartz, M. 1994. Cross talk between the immune system and the nervous system in response to injury: implications for regeneration. FASEB J. 8:1026–1033.

    PubMed  CAS  Google Scholar 

  13. Kennedy, M. K., Torrance, D. S., Picha, K. S., and Mohler, K. M. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496–2502.

    PubMed  CAS  Google Scholar 

  14. Van Damme, J., Rampart, M., Conings, R., Decock, B., Van Osselaer, N., Willems, J., and Billiau, A. 1990. The neutrophilactivating proteins interleukin 8 and beta thromboglobulin: in vitro and in vivo comparison of NH2 terminally processed forms. European J. Immunol. 20:2113–2118.

    Google Scholar 

  15. Loetscher, M., Geiser, T., O’Reilly, T., Zwahlen, R., Baggiolini, M., and Moser, B. 1994. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 269:232–237.

    PubMed  CAS  Google Scholar 

  16. Nakagawa, H., Komorita, N., Shibata, F., Ikesue, A., Konishi, K., Fujioka, M., Kato, H. 1994. Identification of cytokine induced neutrophil chemoattractants (CINC), rat GRO/CINC-2 alpha and CINC-2 beta, produced by granulation tissue in culture: purification, complete amino acid sequences and characterization. Biochemical J. 301:545–550.

    CAS  Google Scholar 

  17. Wu, X., Wittewer, A. J., Carr, L. S., Crippes, B. A., DeLarco, J. E., and Lefkowith, J. B. 1994. Cytokine-induced neutrophil chemoattractant mediates neutrophil influx in immune complex glomerulonephritis in rat. J. Clinical Investigation 94:337–344.

    CAS  Google Scholar 

  18. Smoller, B. R., and Krueger, J. 1991. Detection of cytokine-induced protein gamma-immune protein −10 (gamma IP10) in atypical melanocytic proliferations. J. American Academy of Dermatology, 25:627–631.

    Article  CAS  Google Scholar 

  19. Wilson, S. D., Billings, P. R., D’Eustachio, P., Fournier, R. E., Geissler, E., Lalley, P. A., Burd, P. R., Housman, D. E., Taylor, B. A., and Dorf, M. E. 1990. Clustering of cytokine genes on mouse chromosome 11. J. Experimental Medicine 171:1301–1314.

    Article  CAS  Google Scholar 

  20. Minty, A., Chalon, P., Guillemot, J. C., Kaghad, M., Liauzun, P., Magazin, M., Miloux, B., Minty, C., Ramond, P., and Vita, N. et al. 1993. Molecular cloning of the MCP-3 chemokine gene and regulation of its expression. European Cytokine Network 4:99–110.

    PubMed  CAS  Google Scholar 

  21. Schmouder, R. L., Strieter, R. M., and Kunkel, S. L. 1993. Interferon gamma regulation of human renal cortical epithelial cellderived monocyte chemotactic peptide-1. Kidney International 44:43–49.

    PubMed  CAS  Google Scholar 

  22. Kawahara R. S., Deng, Z. W., Denkinger, D. J., and Deuel, T. F. 1994. Role of serine/threonine protein kinases in the induction of JE, a platelet derived growth factor inducible gene. Biochem. Biophys. Res. Comm. 203:1815–20.

    Article  PubMed  CAS  Google Scholar 

  23. Kuna, P., Reddigari, S. R., Schall, T. J., Rucinski, D., Sadick, M., and Kaplan, A. P. 1993. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J. Immunol. 150:1932–43.

    PubMed  CAS  Google Scholar 

  24. Dahinden, C. A., Geiser, T., Brunner, T., von Tscharner, V., Caput, D., Ferrara, P., Minty, A., and Baggiolini, M. 1994. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J. Exp. Med. 179:751–756.

    Article  PubMed  CAS  Google Scholar 

  25. Luo, Y., Laning, J., and Dorf, M. E. 1993. Serologic analysis of a murine chemokine, TCA3. J. Immunol. 150:971–979.

    PubMed  CAS  Google Scholar 

  26. Rathanaswami, P., Hachicha, M., Sadick, M., Schall, T. J., McColl, S. R. 1993. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J. Biol. Chem. 268:5834–5839.

    PubMed  CAS  Google Scholar 

  27. Bischoff, S. C., Krieger, M., Brunner, T., Rot, A., and von Tscharner, V., Baggiolini, M., and Dahinden, C. A., 1993. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Euro. J. Immunol. 23:761–767.

    CAS  Google Scholar 

  28. Meurer, R., Van Riper, G., Feeney, W., Cunningham, P., Hora, D. Jr., Springer, M. S., McIntyre, D. E., and Rosen, H. 1993. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha or human interleukin 8. J. Exp. Med. 178:1913–1921.

    Article  PubMed  CAS  Google Scholar 

  29. Kojima, K., Berger, T., Lassman, H., Hinze-Selch, D., Zhang, Y., Gehrmann, J., Reske, K., Wekerle, H., and Linington, C. 1994. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J. Exp. Med. 180:817–829.

    Article  PubMed  CAS  Google Scholar 

  30. Wekerle, H., Kojima, K., Lannes-Vieira, J., Lassmann, H. and Linington, C. 1994. Animal models. Annals of Neurology 36 Suppl:S47–53.

    Article  Google Scholar 

  31. Lin, R. F., Lin, T. S., Tilton, R. G., and Cross, A. H. 1993. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J. Exp. Med. 178:643–648.

    Article  PubMed  CAS  Google Scholar 

  32. McCombe, P. A., de Jersey, J., and Pender, M. P. 1994. Inflammatory cells, microglia and MHC class II antigen-positive cells in the spinal cord of Lewis rats with acute and chronic relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 51:153–167.

    Article  PubMed  CAS  Google Scholar 

  33. Shimizu, Y., Newman, W., Tanaka, Y., Shaw, S. 1992. Lymphocyte interactions with endothelial cells. Immunol. Today 13:106–112.

    Article  PubMed  CAS  Google Scholar 

  34. Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G., and Janeway, C. A. Jr. 1993. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:57–68.

    Article  PubMed  CAS  Google Scholar 

  35. Ohmori, K., Hong, Y., Fujiwara, M., and Matsumoto, Y. 1992. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis. Evidence suggesting that most infiltrating T cells do not proliferate in the target organ. Lab. Invest. 66:54–62.

    PubMed  CAS  Google Scholar 

  36. Matsumoto, Y., Hanawa, H., Tsuchida, M., and Abo, T. 1993. In situ inactivation of infiltrating T cells in the central nervous system with autoimmune encephalomyelitis. The role of astrocytes. Immunology 79:381–390.

    PubMed  CAS  Google Scholar 

  37. Weiner, H. L., Friedman, A., Miller, A., Khoury, S. J., al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R. B., Trentham, D. E., and Hafler, D. A. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ specific autoimmune diseases by oral administration of autoantigens. Ann. Rev. of Immunol. 12:809–837.

    Article  CAS  Google Scholar 

  38. Mannie, M. D., Morrison-Plummer, J. and McConnell, T. J. 1993. Differentiation of encephalitogenic T cells confers resistance to an inhibitory anti-CD4 monoclonal antibody. J. Immunol., 151:7293–7306.

    PubMed  CAS  Google Scholar 

  39. Weinberg, A. D., Wyrick, G., Celnick, B., Vainiene, M., Bakke, A., Offner, H., Vandenbark, A. A. 1993. Lymphokine mRNA expression in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis is asociated with a host recruited CD45R hi/CD4+ population during recovery. J. Neuroimmunol., 48:105–17.

    Article  PubMed  CAS  Google Scholar 

  40. Kuchroo, V. K., Martin, C. A., Greer, J. M., Ju, S-T., Sobel, R. A., and Dorf, M. E. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:4371–4382.

    PubMed  CAS  Google Scholar 

  41. Pender, M. P., McCombe, P. A., Yoong, G., and Nguyen, K. B. 1992. Apoptosis of alpha beta T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance. J. Autoimmunity, 5:401–410.

    Article  CAS  Google Scholar 

  42. Schmied, M., Breitschopf, H., Gold, R., Zischler, H., Rothe, G., Wekerle, H., and Lassmann, H. 1993. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 143:446–452.

    PubMed  CAS  Google Scholar 

  43. Dijkstra, C. D., DeGroot, C. J., and Huitinga, I.: The role of macrophages in demyelination. Neuroimmunol. 40:183–188, 1992.

    Article  CAS  Google Scholar 

  44. Hulkower, K., Brosnan, C. F., Aquino, D. A., Cammer, W., Kulshrestha, S., Guida, M. P., Rapoport, D. A., and Berman, J. W. 1993. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J. Immunol. 150:2525–2533.

    PubMed  CAS  Google Scholar 

  45. Nguyen, K. B., McCombe, P. A., and Pender, M. P. 1994. Macrophage apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J. Autoimmun. 7:145–152.

    Article  PubMed  CAS  Google Scholar 

  46. Hickey, W. F., and Kimura, H. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290–292.

    Article  PubMed  CAS  Google Scholar 

  47. Bauer, J., Berkenbosch, F., Van Dam, A. M., and Dijkstra, C. D. 1993. Demonstration of interleukin-1 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level. J. Neuroimmunol. 48:13–21.

    Article  PubMed  CAS  Google Scholar 

  48. Smith, M. E. 1993. Phagocytosis of myelin by microglia in vitro. J. Neurosci. Res. 35:480–487.

    Article  PubMed  CAS  Google Scholar 

  49. Altman, J. 1994. Microglia emerge from the fog. TINS 17:47–49.

    PubMed  CAS  Google Scholar 

  50. Benveniste, E. N. 1993. Astrocyte-microglia interactions. In: S. Murphy, ed., Astrocytes: Pharmacology and Function, Academic Press, Inc., San Diego, pp. 355–382.

    Google Scholar 

  51. Norton, W. T., Brosnan, C. F., Cammer, W., and Goldmuntz, E. A. 1990. Mechanisms and suppression of inflammatory demyelination. Acta Neurobiol. Exp. 50:225–235.

    CAS  Google Scholar 

  52. Claudio, L., Kress, Y., Factor, J., and Brosnan, C. F. 1990. Mechanisms of edema formation in experimental autoimmune encephalomyelitis. The contribution of inflammatory cells. Am. J. Pathol. 137:1033–1045.

    PubMed  CAS  Google Scholar 

  53. Claudio, L., Martiney, J. A. and Brosnan, C. F. 1994. Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha. Lab. Invest. 70: 850–861.

    PubMed  CAS  Google Scholar 

  54. Knobler, R. L., Marini, J. C., Goldowitz, D. and Lublin, F. D. 1992. Distribution of the blood brain barrier in heterotopic brain transplants and its relationship to the lesions of EAE J. Neuropathol. and Exp. Neurol. 51:36–39.

    CAS  Google Scholar 

  55. Cannella, B., Cross, A. H., and Raine, C. S. 1991. Relapsing autoimmune demyelination: a role for vascular addressins. J. Neuroimmunol. 35:295–300.

    Article  PubMed  CAS  Google Scholar 

  56. Cannella, B., Cross, A. H., and Raine, C. S. 1991. Adhesion related molecules in the central nervous system. Upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis. Lab. Invest. 65:23–31.

    PubMed  CAS  Google Scholar 

  57. Raine, C. S., Cannella, B., Duijvestijn, A. M., and Cross, A. H. 1990. Homing to central nervous system vasculature by antigenspecific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab. Invest. 63:476–489.

    PubMed  CAS  Google Scholar 

  58. Seki, T., Joh, K., and Oh-ishi, T. 1993. Augmented production of interleukin-8 in cerebrospinal fluid in bacterial meningitis. Immunology 80:333–335.

    PubMed  CAS  Google Scholar 

  59. Sobel, R. A., Blanchette, B. W., Bhan, A. K., and Colvin, R. B. 1984. The immunopathology of experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell infiltration. J. Immunol. 132:2402–2407.

    PubMed  CAS  Google Scholar 

  60. Myers, K. J., Dougherty, J. P., and Ron, Y. 1993. In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis. J. Immunol. 151:2252–2260.

    PubMed  CAS  Google Scholar 

  61. Rodriguez, M., Scheithauer, B. W., Forbes, G., and Kelly, P. J. 1993. Oligodendrocyte injury is an early event in lesions of multiple sclerosis (see comments) Mayo Clinic Proceedings, 68:627–636.

    PubMed  CAS  Google Scholar 

  62. Chung, I. Y., Norris, J. G., Benveniste, E. N. 1991. Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and-resistant rat strains. J. Exp. Med. 173:801–811.

    Article  PubMed  CAS  Google Scholar 

  63. Selmaj, K., Brosnan, C. F., Raine, C. S. 1991. Expression of heat shock protein-65 by oligodendrocytes in vivo and in vitro: implications for multiple sclerosis. Neurology, 42:795–800.

    Google Scholar 

  64. Kawai, K. and Zweiman, B. 1990. Characteristics of in vitro cytotoxic effects of myelin basic protein-reactive T cell lines on syngeneic oligodendrocytes. J. Neuroimmunol. 26:57–67.

    Article  PubMed  CAS  Google Scholar 

  65. Antel, J. P., Williams, K., Blain, M., McRea, E., and McLaurin, J. 1994. Oligodendrocyte lysis by CD4+ T cells independent of tumor necrosis factor. Annals of Neurol., 35:341–348.

    Article  CAS  Google Scholar 

  66. D’Amelio, F. E., Smith, M. E. and Eng, L. F. 1990. Sequence of tissue responses in the early stages of experimental allergic encephalomyelitis (EAE): immunohistochemical, light microscopic and ultrastructural observations in the spinal cord. Glia 3: 229–240.

    Article  PubMed  CAS  Google Scholar 

  67. Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J., and Lane, T. E. 1993. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol, 151:2132–2141.

    PubMed  CAS  Google Scholar 

  68. Prineas, J. W., Kwon, E. E., Goldenberg, P. Z., Cho, E. S., and Sharer, L. R. 1990. Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions. Lab. Invest. 63:624–636.

    PubMed  CAS  Google Scholar 

  69. Ghatak, N. R. 1992. Occurrence of oligodendrocytes within astrocytes in demyelinating lesions. J. Neuropathol. and Exp. Neurol., 51:40–46.

    CAS  Google Scholar 

  70. Banik, N. L. 1992. Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes. Critical reviews in Neurobiol. 6:257–271.

    CAS  Google Scholar 

  71. Jewtoukoff, V., Amzazi, S., Lebar, R., Bach, M. A., and Marche, P. N. 1992. T cell receptor identification of an oligodendrocytespecific autoreactive cytotoxic T-cell clone without self restriction. Scand. J. Immunol. 36:893–898.

    Article  PubMed  CAS  Google Scholar 

  72. Xiao, B. G., Linington, C., and Link, H. 1991. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 31:91–96.

    Article  PubMed  CAS  Google Scholar 

  73. Massa, P. T., Ozato, K., and McFarlin, D. E. 1992. Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia 8(3):201–207.

    Article  Google Scholar 

  74. Rayner, D. C., Petrycky-Cok, L. D., Diocee, M., and Rector, E. 1993. Major histocompatibility complex class II-restricted cytotoxicity by self-myelin basic protein-reactive T-cell hybridomas: evidence for a tumor necrosis factor independent nucleotytic mechanism. Immunology 78 (2):273–8.

    PubMed  CAS  Google Scholar 

  75. Wucherpfennig, K. W. 1994. Autoimmunity in the central nervous system: mechanisms of antigen presentation and recognition. Clinical Immunology and Immunopathology 72(3):293–306.

    Article  PubMed  CAS  Google Scholar 

  76. Bergsteindottir, K., Brennan, A., Jessen, K. R. and Mirsky, R. 1992. In the presence of dexamethasone gamma interferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 89: 9054–9058.

    Article  PubMed  CAS  Google Scholar 

  77. Li, Y., Atashi, J., Hayes, C., Reap, E., Hunt, S. 3rd, and Popko, B. 1995. Morphological and molecular response of the MOCH-1 oligodendrocyte cell line to serum and interferon-gamma: possible implications for demyelinating disorders. J. Neuroscience Res. 40(2):189–198.

    Article  CAS  Google Scholar 

  78. Eng, L. F., and Ghirnikar, R. S. 1994. GFAP and astrogliosis. Brain Pathol. 4:229–237.

    PubMed  CAS  Google Scholar 

  79. Eng, L. F., and Lee, Y. L. 1995. Intermediate filaments in astrocytes. Pages 650–667.in H. Kettenmann and B. R. Ransom, eds., Neuroglia, Oxford University Press, New York.

    Google Scholar 

  80. Smith, M. E., and Eng, L. F. 1987. The Immune System in Neuropathology. Glial fibrillary acidic protein in chronic relapsing experimental allergic encephalomyelitis in SJL/J mice. Neurosci. Res. 18:203–208.

    Article  CAS  Google Scholar 

  81. Ludowyk, P. A., Hughes, W., Hugh, A., Willenborg, D. O., Rockett, K. A., and Parish, C. R. 1993. Astrocytic hypertrophy: an important pathological feature of chronic experimental autoimmune encephalitis in aged rats. J. Neuroimmunol. 48:121–134.

    Article  PubMed  CAS  Google Scholar 

  82. Smith, M. E., Somera, F. P., Eng, L. F. 1983. Immunocytochemical staining for glial fibrillary acidic protein and the metabolism of cytoskeletal proteins in experimental allergic encephalomyelitis. Brain Res 264:241–253.

    Article  PubMed  CAS  Google Scholar 

  83. Goldmuntz, E. A., Brosnan, C. F., Chiu, F.-C., and Norton, W. T. 1986. Astrocytic reactivity and intermediate filament metabolism in experimental autoimmune encephalomyelitis: the effect of suppression with prazosin. Brain Res. 397:16–26.

    Article  PubMed  CAS  Google Scholar 

  84. Cutler, R. W. P., Lorenzo, A. V., and Barlow, C. F. 1967. Brain vascular permeability to I125 gamma globulin and leukocytes in allergic encephalomyelitis. J. Neuropathol. Exp. Neurol. 26:558–571.

    PubMed  CAS  Google Scholar 

  85. Levine, S., Simar, J., and Wenk, E. J. 1966. Edema of the spinal cord in experimental allergic encephalomyelitis. Proc. Soc. Exp. Biol. Med. 123:539–541.

    PubMed  CAS  Google Scholar 

  86. Juhler, M., Barry, D. I., Offner, H., Konat, G., Klinken, L., and Paulson, O. B. 1984. Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res. 302:347–355.

    Article  PubMed  CAS  Google Scholar 

  87. Eng, L. F., D’Amelio, F. E., and Smith, M. E., 1989. Dissociation of GFAP intermediate filaments in EAE: observations in the lumbar spinal cord. Glia 2:308–317.

    Article  PubMed  CAS  Google Scholar 

  88. Lee, J. C. 1982. Anatomy of the blood-brain barrier under normal and pathological conditions. In:Histology and Histopathology of the Nervous system. W. Haymaker and R. D. Adams, eds., Charles Thomas, pp. 798–890.

  89. Miquel, J., Foncin, J.-F., Gruner, J. E., and Lee, J. C. 1982. Cerebral edema. In: W. Haymaker and R. D. Adams, eds. Histology and Histopathology of the Nervous System, Charles Thomas, pp. 871–919.

  90. Bourke, R. S., Kimelberg, H. K., Nelson, L. R., Barron, K. D., Auen, E. L., Popp, A. J., and Waldman, J. B. 1980. Biology of glial swelling in experimental brain edema. In: J. Cervos-Navarro and R. Ferszt, eds., Brain Edema. Pathology, Diagnosis, and Therapy, Advances in Neurology, Vol. 28., pp. 99–109.

  91. Chan, P. H. and Fishman, R. A. 1985. Brain edema. In: A. Lajtha, ed., Handbook of Neurochemistry, Plenum Press, New York, pp. 153–174.

    Google Scholar 

  92. Halliwell, B., and Gutteridge, J. M. C. 1985. Oxygen radicals and the nervous system. Trends Neurosci. 8:22–26.

    Article  CAS  Google Scholar 

  93. Wahl, M., Unterberg, A., Baethmann, A., and Schilling, L. 1988. Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. J. Cerebral Blood Flow Metab. 8:621–634.

    CAS  Google Scholar 

  94. Kimelberg, H. K., Bourke, R. S., Stieg, P. E., Barron, K. D., Hirata, H., Pelton, E. W., and Nelson, L. R. 1982. Swelling of astroglia after injury to the central nervous system: Mechanisms and consequences. Pages 31–44.in: R. G. Grossman and P. L. Gildenberg, (eds.), Head Injury: Basic and Clinical Aspects, Raven Press, New York.

    Google Scholar 

  95. Aquino, D. A., Chiu, F.-C., Brosnan, C. F., and Norton, W. T. 1988. Glial fibrillary acidic protein increases in the spinal cord of Lewis rats with acute experimental autoimmune encephalomyelitis. J. Neurochem. 51:1085–1096.

    Article  PubMed  CAS  Google Scholar 

  96. Kothavale, A., Gregoria, D. D., Somera, F. P., and Smith, M. E. 1995. GFAP mRNA fluctuates in synchrony with chronic relapsing EAE symptoms in SJL/J mice. Glia 14:216–224.

    Article  PubMed  CAS  Google Scholar 

  97. Balasingam, V., Tejada-Berges, T., Wright, E., Bouckova, R., and Yong, V. W. 1994. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci. 14: 846–856.

    PubMed  CAS  Google Scholar 

  98. Eddleston, M., and Mucke, L. 1993. Molecular profile of reactive astrocytes; implications for their role in neurologic diseases. Neuroscience 54:15–36.

    Article  PubMed  CAS  Google Scholar 

  99. Rudge, J. S. 1993. Astrocyte-Derived Neurotrophic factors. In: S. Murphy, ed., Astrocytes: Pharmacology and Function, Academic Press, Inc., San Diego, pp. 267–305.

    Google Scholar 

  100. Shrikant, P., Chung, I. Y., Ballestas, M. E., and Benveniste, E. N. 1994. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma in astrocytes. J. Neuroimmunol., 51:209–220.

    Article  PubMed  CAS  Google Scholar 

  101. Murphy, G. M., Jr., Jia, X-C., Yu, A. C. H., Lee, Y. L., Tinklenberg, J. R., and Eng, L. F. 1993. Reverse transcription-PCR for quantification of mRNA in primary astrocyte cultures. J. Neurosci. Res. 35:643–651.

    Article  PubMed  CAS  Google Scholar 

  102. Murphy, G. M., Jr., Lee, Yuen Ling, Jia, Xiao-Chi, Yu, Albert C. H., Majeewska, Anna, Song, Yaoli, Schmidt, Karen, and Eng, L. F. 1995. Tumor Necrosis Factor alpha and Basic Growth Factor Decrease Glial Fibrillary Acidic Protein and its Encoding mRNA in Astrocyte Cultures and Glioblastoma Cells, J. Neurochem., 65:2716–2724.

    Article  PubMed  CAS  Google Scholar 

  103. Rubio, N., and Capa, L. 1993. Differential IL-1 synthesis by astrocytes from Theiler’s murine encephalomyelitis virus-susceptible and-resistant strains of mice. Cellular Immunol. 149:237–247.

    Article  CAS  Google Scholar 

  104. Endoh, M., Maiese, K., and Wagner, J. 1994. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res. 651:92–100.

    Article  PubMed  CAS  Google Scholar 

  105. Galea, E., Reis, D. J., and Feinstein, D. L. 1994. Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J. Neurosci. Res. 37:406–414.

    Article  PubMed  CAS  Google Scholar 

  106. Cross, A. H., Misko, T. P., Lin, R. F., Hickey, W. F., Trotter, J. L., Tilton, R. G. 1994. A minoguanidine, an inhibitor of inducible oxide synthase ameliorates experimental autommmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:2684–2690.

    Article  PubMed  CAS  Google Scholar 

  107. Brenner, T., Brocke, S., Szafer, F., and Steinman, L. 1995. Inhibition of nitric oxide synthase for the treatment of experimental autoimmune encephalomyelitis. J. Neurochem. 64 Suppl. S4D.

    Google Scholar 

  108. Kaprowski, H., Zheng, Y. M., Heber-Katz, E., Fraser, N., Rorke, L., Fu, Z. F., Hanlon, C., and Dietzschold, B. 1993. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA 90: 3024–3027.

    Article  Google Scholar 

  109. Merrill, J. E., Kono, D. H., Clayton, J., Ando, D. G., Hinton, D. R.; and Hofman, F. M. 1992. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10-PL mice (published erratum appears in Proc. Natl. Acad. Sci. USA 89:10562, 1992), Proc. Natl. Acad. Sci. 89:574–578.

    Article  PubMed  CAS  Google Scholar 

  110. DeGroot, C. J., Sminia, T., Dijkstra, C. D., Van der Pal, R. H., Lopes-Cardozo, M. 1991. Interferon-gamma induced IA antigen expression on cultured neuroglia cells and brain macrophages from rat spinal cord and cerebrum. International J. Neurosci. 59: 53–65.

    Article  CAS  Google Scholar 

  111. Halachmi, E., Ben-Nun, A., Lehman, D., Karussis, D., Wekerle, H. and Berke, G. 1992. Delineation of tissue damage mechanisms in experimental autoimmune encephalomyelitis (EAE). I. Cell detachment and lysis induced by encephalitogenic CD4+ T lymphocytes. J. Autoimmunity 5:411–425.

    Article  CAS  Google Scholar 

  112. Halachmi, E., Pinkus, R., Miron, S., Ben-Nun, A., Wekerle, H., and Berke, G. 1992. Delineation of tissue damage mechanisms in experimental autoimmune encephalomyelitis (EAE). II. Characteristics of astrocyte detachment mediated by myelin basic protein (MBP) specific CD4+ T lymphocytes J. Autoimmunity 5: 427–441.

    Article  CAS  Google Scholar 

  113. Baker, D., O’Neill, J. K., and Turk, J. L. 1991. Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell Immunol. 134:505–510.

    Article  PubMed  CAS  Google Scholar 

  114. Weinberg, A. D., Wyrick, G., Celnick, B., Vainiene, M., Bakke, A., Offner, H., and Vandebark, A. A. 1993. Lymphokine mRNA expression in the spinal cords of Lewis rats with exprimental autoimmune encephalomyelitis is associated with host recruited CD45R hi/CD4+ population during recovery. J. Neuroimmunol. 48:105–118.

    Article  PubMed  CAS  Google Scholar 

  115. Godiska, R., Chantry, D., Dietsch, G. N., and Gray, P. W. 1995. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58:167–176.

    Article  PubMed  CAS  Google Scholar 

  116. Lee, Y. L., Smith, M. E., Kou, A., Wang, J., and Eng, L. F. 1995. Cytokine mRNAs in the spinal cord of mice with EAE. J. Neurochem. 64 (Suppl.) S91D.

    Google Scholar 

  117. Racke, M. K., Dhib-Jalbut, S., Cannella, B., Albert, P. S., Raine, C. S., and McFarlin, D. E. 1991. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor beta 1. J. Immunol. 146:3012–3017.

    PubMed  CAS  Google Scholar 

  118. Racke, M. K., Sriram, S., Carlino, J., Cannella, B., Raine, C. S., and McFarlin, D. E. 1993. Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2. J. Neuroimmunol. 46:175–183.

    Article  PubMed  CAS  Google Scholar 

  119. Johns, L. D., Flanders, K. C., Raanges, G. E., and Sriram, S. Successful treatment of experimental autoimmune encephalomyelitis with transforming growth factor-β-1. J. Immunol. (1991) 147:11792–1796.

    Google Scholar 

  120. Gao, Y. L., Brosnan, C. F., and Raine, C. S. 1995. Experimental Autoimmune Encephalomyelitis: Qualitative and semiquantitative differences in heat shock protein 60 expression in the central nervous system. J. Immunol. 154:3548–3556.

    PubMed  CAS  Google Scholar 

  121. Issazadeh, S., Mustafa, M., Ljungdahl, A., Hojeberg, B., Dagerlind, A., Elde, R., and Olsson, T. 1995. Interferon γ, Interleukin 4 and Transforming Growth Factor β in Experimental Autoimmune Encephalomyelitis in Lewis Rats: Dynamics of Cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res. 40:579–590.

    Article  PubMed  CAS  Google Scholar 

  122. Racke, M. K., Burnett, D., Pak, S-H., Albert, P. S., Cannella, B., Raine, C. S., McFarlin, D. E., and Scott, D. E. 1995. Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course. J. Immunology 154:450–458.

    CAS  Google Scholar 

  123. Santambrogio, L., Hochwald, G. U., Saxena, B., Lev, C. H., Martz, J. E., Carlino, J. A., Ruddle, N. H., Palladino, M. A., Gold, L. I., and Thorbecke, G. J. 1993. Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. J. Immunol. 153:1116–1127.

    Google Scholar 

  124. Yu, A. C. H., Lee, Y. L., and Eng, L. F. 1991. Inhibition of GFAP synthesis by antisense RNA in astrocytes. J. Neurosci. Res. 30:72–79.

    Article  PubMed  CAS  Google Scholar 

  125. Yu, A. C. H., Lee, Y. L., and Eng, L. F. 1993. Astrogliosis in culture. I. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis. J. Neurosci. Res. 34: 295–303.

    Article  PubMed  CAS  Google Scholar 

  126. Ghirnikar, R. S., Yu, A. C. H., and Eng, L. F. 1994. Astrogliosis in culture III. Effect of recombinant retrovirus expressing antisense glial fibrillary acidic protein RNA. J. Neurosci. Res. 38: 376–385.

    Article  PubMed  CAS  Google Scholar 

  127. Fisher, L. J. and Gage, F. D. 1994. Intracerebral transplantation: basic and clinical applications to the neostriatum. FASEB, 8: 489–496.

    CAS  Google Scholar 

  128. Logan, A., Berry, M., Gonzalez, A. M., Frautschy, S. A., Sporn, M. B., and Baird, A. 1994. Effects of transforming growth factor b1 on scar production in the injured central nervous system of the rat. Eur. J. Neurosci. 6:355–363.

    Article  PubMed  CAS  Google Scholar 

  129. Logan, A., Frautschy, S. A., Gonzalez, A-M., Sporn, M. B., and Baird, A. 1992. Enhanced expression of transforming growth factor b1 in the rat brain after a localized cerebral injury. Brain Res. 587:216–225.

    Article  PubMed  CAS  Google Scholar 

  130. Panitch, H. S. 1994. Influence of infection on exacerbations of multiple sclerosis. Annals of Neurology, 36 Suppl:S25–8.

    Article  Google Scholar 

  131. Panitch, H. S., and Bever, C. T. Jr. 1993. Clinical trials of interferons in multiple sclerosis. What have we learned? J. Neuroimmunol. 46(1–2):155–64.

    Article  PubMed  CAS  Google Scholar 

  132. McFarland, H. F. 1995. Therapeutic approaches to multiple sclerosis. J. Neurochem. 64 Suppl. S73C.

    Google Scholar 

  133. Weber, F. and Rieckmann, P. 1995. Pathogenesis and therapy of multiple sclerosis. The role of cytokines Nervenarzt 66(2):150–155.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Veteran Affairs Palo Alto Health Care System, 3801 Miranda Ave., 94304, Palo Alto, CA

    Lawrence F. Eng & Yuen Ling Lee

  2. Stanford University School of Medicine, 94305, Stanford, CA

    Lawrence F. Eng, Roopa S. Ghirnikar & Yuen Ling Lee

Authors
  1. Lawrence F. Eng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roopa S. Ghirnikar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuen Ling Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Special issue dedicated to Dr. Marion E. Smith.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eng, L.F., Ghirnikar, R.S. & Ling Lee, Y. Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem Res 21, 511–525 (1996). https://doi.org/10.1007/BF02527717

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02527717

Key words

Search

Navigation